KLK3 and prostate carcinoma: Receiver operator characteristic (ROC) curves were used to determine whether coding and non-coding prostate cancer biomarkers could differentiate BxPos (n=47) from BxNeg patients (n=39) using exoRNA standardised to the prostate marker KLK3.